XML 18 R6.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2024   72,741,321        
Beginning balance at Jan. 31, 2024 $ 1,068,989 $ 73 $ 2,777,322 $ (1,319) $ 4,545 $ (1,711,632)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock option exercises (in shares)   132,617        
Stock option exercises 953   953      
Vesting of restricted stock units (in shares)   399,213        
Vesting of performance stock units (in shares)   77,444        
Issuance of common stock in connection with a business combination 0          
Stock-based compensation 120,763   120,763      
Unrealized gain on available-for-sale securities (9,541)       (9,541)  
Foreign currency translation adjustment (1,007)       (1,007)  
Reclassification of derivative related to the Capped Call associated with the 2024 Notes 169,692   169,692      
Net loss (80,593)         (80,593)
Ending balance (in shares) at Apr. 30, 2024   73,350,595        
Ending balance at Apr. 30, 2024 $ 1,269,256 $ 73 3,068,730 (1,319) (6,003) (1,792,225)
Beginning balance (in shares) at Jan. 31, 2025 80,467,811 80,467,811        
Beginning balance at Jan. 31, 2025 $ 2,782,224 $ 78 4,625,093 (1,319) (924) (1,840,704)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock option exercises (in shares) 77,519 77,519        
Stock option exercises $ 579   579      
Vesting of restricted stock units (in shares)   381,937        
Vesting of restricted stock units 1 $ 1        
Vesting of performance stock units (in shares)   91,319        
Issuance of common stock in connection with a business combination subject to future vesting (in shares)   213,023        
Issuance of common stock in connection with a business combination (in shares)   484,169        
Issuance of common stock in connection with a business combination 141,402 $ 1 141,401      
Stock-based compensation 132,431   132,431      
Unrealized gain on available-for-sale securities 6,858       6,858  
Foreign currency translation adjustment 7,081       7,081  
Net loss $ (37,626)         (37,626)
Ending balance (in shares) at Apr. 30, 2025 81,715,778 81,715,778        
Ending balance at Apr. 30, 2025 $ 3,032,950 $ 80 $ 4,899,504 $ (1,319) $ 13,015 $ (1,878,330)